This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cerebral Palsy
and you are
between 6 and 3
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This purpose of this phase 1 study is to investigate the safety and efficacy of erythropoetin for children with cerebral palsy.

Provided treatments

  • Drug: Erythropoietin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01586052. The sponsor of the trial is MinYoung Kim, M.D. and it is looking for 11 volunteers for the current phase.
Official trial title:
A Phase 1 Clinical Research of Erythropoietin Therapy for Children With Cerebral Palsy: Safety and Efficacy